Neil A. Halpern

  • ADJUNCT ASSOCIATE PROFESSOR Surgery
  • ADJUNCT ASSOCIATE PROFESSOR Medicine
Print ProfilePrint Profile

Specialty

Certifications

  • Critical Care Medicine

  • American Board of Internal Medicine

Education

  • MD, Mount Sinai School of Medicine

  • B.A., Yeshiva University

  • M.D., Mount Sinai School of Medicine

  • The Mount Sinai Hospital
    Internal Medicine

  • University Health Center of Pittsburgh
    Critical Care Medicine

  • Residency, Internal Medicine
    Mount Sinai Hospital

  • Residency, Internal Medicine
    Mount Sinai Hospital

  • Fellowship, Critical Care
    University Health Ctr of Pittsburg

Biography

    Mailing Address
    Memorial Sloan-Kettering Cancer Center
    1275 York Avenue, Room M210
    New York, NY 10021

Awards

  • 2003 - 2006
    Physician's Recognition Award
    American Medical Association

  • 2001 -
    Top Doctors New York Metro Area
    Castle Connolly Medical, Ltd.

  • 2000 -
    Physician's Recognition Award
    American Medical Association

  • 1998 -
    Certificate of Special Achievement
    Department of Veterans Affairs Medical Center, Bronx, NY

  • 1997 -
    Physician's Recognition Award
    American Medical Association

  • 1993 -
    Certificate of Appreciation
    Department of Veterans Affairs Medical Center, Bronx, NY

  • 1993 -
    Physician's Recognition Award
    American Medical Association

  • 1992 -
    Fellowship
    American College of Critical Care Medicine (FCCM)

  • 1991 -
    Fellowship
    American College of Angiology (FACA)

  • 1990 -
    Physician's Recognition Award
    American Medical Association

  • 1990 -
    Fellowship
    American College of Chest Physicians (FCCP)

  • 1990 -
    Certificate of Appreciation
    Department of Veterans Affairs Medical Center, Bronx, NY

  • 1990 -
    Fellowship
    American College of Physicians (FACP)

  • 1988 -
    Special Achievement Award
    Department of Veterans Affairs Medical Center, Bronx, NY

  • 1986 -
    Who's Who in the East
    Marquis Who's Who New Providence, NJ

  • 1986 - Present
    Who's Who in the East
    Marquis Who's Who, New Providence, NJ

  • 1977 -
    Who's Who Among Students in American Colleges and Universities
    Marquis Who's Who, New Providence, NJ

  • 1977 -
    Cum Laude
    Yeshiva University

Research

A double blind, placebo controlled study of E5564, A Lipid A Antagonist administered by twice daily intravenous infusions in patients with severe sepsis

A multi-center randomized, double blind, parallel group-placebo controlled trial on efficacy and safety of activated Recombinant Factor VII (rFVIIa/NovoSeven ) in the treatment of bleeding in patients following hematopoietic stem cell transplantation

A Safety evaluation of Xigris (Drotecogin alfa activated) in Hematopoietic Stem Cell Transplant Patients with Severe Sepsis

Publications

Castro HJ, Oropello JM, Halpern NA. Point of care testing in the intensive care unit: The intensive care physicians perspective. Pathology Patterns. Am J Clin Pathol 1995; 104(Suppl): S95-S99.

Halpern NA, Morgan S, Miller P, Greenstein RG. Remote communication from a mobile terminal: An adjunct for a computerized ICU order management system. Critical Care Medicine 1995; 23: 2054-2057.

Halpern NA, Colucci RD, Thompson R, Alicea M, London E, Greenstein RG. Computerized ICU orders versus handwritten orders: A prospective, pharmacy based analysis. American J Therapeutics 1995; 2: 279-282.

Halpern NA. Today's strategies for managing postoperative hypertension. J Critical Illness 1995; 10: 478-490.

Kanneganti M, Halpern NA. Acute hypertension and calcium channel blockers. New Horizons: The Science and Practice of Acute Medicine 1996; 4(1): 19-25.

Halpern NA, Alicea M, Seabrook B, Spungen A, McElhinney AJ, Greenstein RJ. Cell saver autologous transfusion: Metabolic consequences of washing blood with normal saline. Journal of Trauma: Injury, Infection and Critical Care 1996; 41(3): 407-415.

Siegel RE, Halpern NA, Almenoff PL, Lee A, Cashin R, Greene JG. A prospective randomized study of inpatient intravenous antibiotics for community acquired pneumonia: the optimal duration of therapy. Chest 1996; 110(4): 965-971.

Halpern NA, Alicea M, Seabrook B, Spungen A, Greenstein R. Isolyte S, a physiologic multi-electrolyte solution, is preferable to normal saline to wash cell saver salvaged blood: Conclusions from a prospective, randomized study in a canine model. Critical Care Medicine 1997; 25(12): 2031-2038.

Halpern NA, Brentjens T. A point-of-care laboratory testing program in the ICU: Thoughts for hospital laboratorians. Medical Laboratory Observer (MLO) Supp 1998; 9: 12-17.

Halpern NA. Technology introduction in critical care: Just knowing the price is not enough. Chest 1999; 116: 1092-1099.

Halpern NA, Pastores S, Baker-Price J, Alicea M. Hearing loss in the critically ill: An unappreciated phenomenon. Critical Care Medicine 1999; 27: 211-219.

Sedlacek M, Halpern NA, Uribarri J. Carboxyhemoglobin and lactate levels do not correlate in critically ill patients. American Journal of Therapeutics 1999; 6: 241-244.

Halpern NA, Brentjens T. Point of care testing informatics: The critical care-hospital interface. Critical Care Clinics 1999; 15: 577-591.

Pastores S, Halpern NA. Acquisition strategies for critical care technology . Critical Care Clinics 2000; 16: 545-557.

Maguire PJ, Stevens C, Humes HD, Shander A, Pastores S, Halpern NA. Bioartificial organ support for hepatic, renal and hematologic failure. Critical Care Clinics 2000; 16: 681-694.

Halpern NA. Point of care diagnostics and networks. Critical Care Clinics 2000; 16: 623-640.

Halpern NA. Point-of-care testing in the ICU, Part 2: Implementation is all. Journal of Critical Illness 2002; 17: 240-244.

Pastores SP, Papadopoulos E, Alicea M, van den Brink M, Halpern N. Septic shock and multiple organ failure after Hematopoietic stem cell transplantation: treatment with recombinant human activated protein C. Bone Marrow Transplantation 2002; 30: 131-134.

Halpern NA. Point-of-care testing in the ICU, Part 1: The driving technology. Journal of Critical Illness 2002; 17: 182-187.

Pastores SP, Papadopoulos E, Voigt L, Halpern N. Diffuse alveolar hemorrhage after allogeneic hematopoietic stem cell transplantation: Treatment with recombinant factor VIIa. Chest 2003; 124: 2400-2403.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr.Halpern is not currently required to report Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central

Memorial Hospital Department Of Surgery

1275 York Avenue
Room C1179
New York, NY 10021

Tel: 212-639-6731
Fax: 212-794-4333

Get Directions